Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A study assessing CMC-001 in healthy volunteers with different degrees of hepatic impairment

Next Previous
Trial Profile

A study assessing CMC-001 in healthy volunteers with different degrees of hepatic impairment

Status: Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 22 Aug 2023

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs CMC 001 (Primary)
  • Indications Liver disorders
  • Focus Adverse reactions; Diagnostic use; Pharmacodynamics; Pharmacokinetics; Registrational

Most Recent Events

  • 18 Aug 2023 According to an Ascelia Pharma media release, this hepatic impairment study has been accepted for presentation at major radiology and liver conferences.
  • 24 Jun 2023 Results assessing safety and change in MRI signal intensity in the liver over time after a single dose of Orviglance presented at the European Association for the Study of the Liver Congress 2023
  • 16 Jun 2023 According to an Ascelia Pharma media release, data from this study were presented at the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) Annual Meeting in Valencia, Spain, June 13-16, 2023.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top